alendronate has been researched along with Benign Monoclonal Gammopathies in 1 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with alendronate could lead to a significant reduction in fracture risk in MGUS patients with skeletal fragility." | 1.35 | The effects of alendronate treatment in osteoporotic patients affected by monoclonal gammopathy of undetermined significance. ( Fassino, V; Mascia, ML; Minisola, S; Pepe, J; Petrucci, MT; Piemonte, S; Romagnoli, E, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pepe, J | 1 |
| Petrucci, MT | 1 |
| Mascia, ML | 1 |
| Piemonte, S | 1 |
| Fassino, V | 1 |
| Romagnoli, E | 1 |
| Minisola, S | 1 |
1 other study available for alendronate and Benign Monoclonal Gammopathies
| Article | Year |
|---|---|
The effects of alendronate treatment in osteoporotic patients affected by monoclonal gammopathy of undetermined significance.
Topics: Alendronate; Alkaline Phosphatase; Biomarkers; Bone Density; Bone Density Conservation Agents; Calci | 2008 |